cells

Minerva Biotechnologies – Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells

Minerva Biotechnologies – Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells

Minerva Biotechnologies – Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells

Karren Franco 3 June، 2025

WALTHAM, Mass. Minerva Biotechnologies published “Effective CAR T cell targeting of a MUC1 cleavage product” in the...

Department of Health – Abu Dhabi, through Abu Dhabi Stem Cells Center, introduces advanced gene-editing therapy for sickle cell disease and thalassemia for first time in UAE دائرة الصحة – أبوظبي توفِّر علاجاً بتقنية التحرير الجيني يقدمه مركز أبوظبي للخلايا الجذعية لمرضى فقر الدم المنجلي والثلاسيميا للمرة الأولى في دولة الإمارات

دائرة الصحة – أبوظبي توفِّر علاجاً بتقنية التحرير الجيني يقدمه مركز أبوظبي للخلايا الجذعية لمرضى فقر الدم المنجلي والثلاسيميا للمرة الأولى في دولة الإمارات

Department of Health – Abu Dhabi, through Abu Dhabi Stem Cells Center, introduces advanced gene-editing therapy for sickle cell disease and thalassemia for first time in UAE

DGN Gate 29 March، 2025

Abu Dhabi, 28 March 2025: The Department of Health – Abu Dhabi (DoH) has announced the introduction...